Adverum Biotechnologies Announces $127.5 Million Private Placement Financing
– Financing led by TCGX with participation from new and existing investors including 5AM Ventures, Commodore Capital, Frazier Life Sciences, Logos Capital, Samsara BioCapital, Venrock Healthcare Capital Partners and Vivo Capital, as well two large investment management firms.
Related news for (ADVM)
- MoBot’s Stock Market Highlights – 09/23/25 11:00 AM
- Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones
- Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD
- Adverum Biotechnologies Announces Positive 52-Week LUNA and 4-Year OPTIC Results, and Provides Key Pivotal Program Design Elements
- adverum biotechnologies appoints jason l. mitchell as chief commercial officer as it prepares to initiate pivotal program